Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
Ferreira T, Huber SC, de Moraes Martinelli B, Junior AL, Menezes FH, Orsi FA, Bittar LF, de Oliveira LFG, Sodre LR, Mello TT, Rielli G, Colella MP, de Paula EV, Yamaguti-Hayakawa GG, Montalvão S, Annichino-Bizzacchi JM. Ferreira T, et al. Among authors: huber sc. Vascul Pharmacol. 2020 Jan;124:106608. doi: 10.1016/j.vph.2019.106608. Epub 2019 Oct 31. Vascul Pharmacol. 2020. PMID: 31678199
Treatment of male pattern alopecia with platelet-rich plasma: A double-blind controlled study with analysis of platelet number and growth factor levels.
Rodrigues BL, Montalvão SAL, Cancela RBB, Silva FAR, Urban A, Huber SC, Júnior JLRC, Lana JFSD, Annichinno-Bizzacchi JM. Rodrigues BL, et al. Among authors: huber sc. J Am Acad Dermatol. 2019 Mar;80(3):694-700. doi: 10.1016/j.jaad.2018.09.033. Epub 2018 Oct 2. J Am Acad Dermatol. 2019. PMID: 30287324 Clinical Trial.
From Hemophilia to Deep Venous Thrombosis Patient Samples: How to Perform an Easy Coagulometer Validation Process According to Available Guidelines.
Montalvão SAL, Francisco AP, da Silva BLQ, Huber SC, Aguiari HJ, Fernandes MCGL, Elidio PS, Martinelli BM, Tony IM, Colella MP, Annichinno-Bizzachi JM. Montalvão SAL, et al. Among authors: huber sc. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620915512. doi: 10.1177/1076029620915512. Clin Appl Thromb Hemost. 2020. PMID: 32491936 Free PMC article.
Corrigendum to "Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban" [Vascular Pharmacology 124 (2020)/106608].
Ferreira T, Huber SC, de Moraes Martinelli B, Junior AL, Menezes FH, Orsi FA, Bittar LF, de Oliveira LFG, Sodre LR, Mello TT, Rielli G, Colella MP, de Paula EV, Yamaguti Hayakawa GG, Montalvão S, Annichino-Bizzacchi JM. Ferreira T, et al. Among authors: huber sc. Vascul Pharmacol. 2020 Oct-Nov;133-134:106780. doi: 10.1016/j.vph.2020.106780. Epub 2020 Aug 28. Vascul Pharmacol. 2020. PMID: 32868216 No abstract available.
Misdiagnosis of high thrombotic risk triple-positive antiphospholipid antibodies.
De Lima Montalvão SA, Colella MP, Fernandes MC, Huber SC, Francisco AP, Soares SM, Miranda LD, Aguiari HJ, Elídio PS, Yamaguti G, De Paula EV, Orsi FA, Annichinno-Bizzacchi JM. De Lima Montalvão SA, et al. Among authors: huber sc. Thromb Res. 2021 Jan;197:33-35. doi: 10.1016/j.thromres.2020.10.016. Epub 2020 Oct 23. Thromb Res. 2021. PMID: 33161285 No abstract available.
212 results